| Filename | Document Type | Assessment Tool | Status | Quality Score | Created Time | Data Source | Actions |
|---|---|---|---|---|---|---|---|
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
68.8%
11/16 passed |
2025-10-07 12:55:32 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-10-07 12:55:32 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-10-07 12:55:32 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-10-07 12:55:32 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-10-07 12:55:32 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-10-07 12:55:32 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
68.8%
11/16 passed |
2025-10-07 12:55:32 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-10-07 12:55:32 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
81.2%
13/16 passed |
2025-10-07 12:55:32 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-10-07 12:55:32 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-10-07 12:55:32 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-10-07 12:55:32 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-10-07 12:55:32 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-10-07 12:55:32 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
68.8%
11/16 passed |
2025-10-07 12:55:32 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-10-07 12:55:32 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
81.2%
13/16 passed |
2025-10-07 12:55:32 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
50.0%
8/16 passed |
2025-10-07 12:55:32 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
25.0%
2/8 passed |
2025-10-07 12:55:32 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
50.0%
8/16 passed |
2025-10-07 12:55:32 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-10-07 12:55:32 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-10-07 12:55:32 | ||
| joc-26-03-190.pdf | Unknown | - | Completed | - | 2025-10-07 12:55:32 | ||
| joc-26-03-190.pdf | Other | - | Completed | - | 2025-10-07 12:55:32 | ||
| Evaluation_of_long-term_benefits_and_cost-effectiveness_ofnation-wide_colorectal_cancer_screening_strategies_in_China_in20202060__a_modelling_analysis.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-10-07 12:55:32 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-10-07 12:55:32 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-10-07 12:55:32 | ||
| Camaione_2013_tham_inh_mo_hinh.pdf | Unknown | - | Completed | - | 2025-10-07 12:55:32 | ||
| systematic_review_vancomycin_model_pediatric.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
31.2%
5/16 passed |
2025-10-07 12:55:32 | ||
| systematic_review_vancomycin_model_pediatric.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-10-07 12:55:32 | ||
| Li-2021-popPK-Vanco-ARC.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-10-07 12:55:32 | ||
| joc-26-03-190.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-10-07 12:55:32 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-10-07 12:55:32 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-10-07 12:55:32 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
68.8%
11/16 passed |
2025-10-07 12:55:32 | ||
| sustainability-14-01724-v2.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-10-07 12:55:32 | ||
| peltier-et-al-2007-the-interdependence-of-the-factors-influencing-the-perceived-quality-of-the-online-learning.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-10-07 12:55:32 | ||
| sustainability-13-02752.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-10-07 12:55:32 | ||
| sustainability-14-08138-v2.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-10-07 12:55:32 | ||
| Education_for_sustainable_development_in_higher_education_evaluating_coherence_between_theory_and_praxis.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-10-07 12:55:32 | ||
| sustainability-13-03524-v2.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-10-07 12:55:32 | ||
| sustainability-13-12354-v2_1.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-10-07 12:55:32 | ||
| sustainability-13-12354-v2.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-10-07 12:55:32 | ||
| Chapter_4_-_Building_credibility_from_day_zero_-_Short.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-10-07 12:55:32 | ||
| Widding_et_al._-_2009_-_University-affiliated_Venture_Capital_funds_fundi.pdf | Unknown | - | Completed | - | 2025-10-07 12:55:32 | ||
| PRISMA_2020_flow_diagram_new_SRs_v1.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-10-07 12:55:32 | ||
| Cai_2021.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
23.1%
3/13 passed |
2025-10-07 12:55:32 | ||
| Fang_2017_1.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
15.4%
2/13 passed |
2025-10-07 12:55:32 | ||
| Rampello_2019.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
30.8%
4/13 passed |
2025-10-07 12:55:32 | ||
| Rowin_2000.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
15.4%
2/13 passed |
2025-10-07 12:55:32 | ||
| Sartucci_2010.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
7.7%
1/13 passed |
2025-10-07 12:55:32 | ||
| Srotova_2017.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
30.8%
4/13 passed |
2025-10-07 12:55:32 | ||
| Neutrophil_Gelatinase-_Associated_Lipocalin_in_the_Early_Diagnosis_of_Peritonitis-_The_Case_of_Neutrophil_Gelatinase-_Associated_Lipocalin.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
0.0%
0/13 passed |
2025-10-07 12:55:32 | ||
| Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| BadaamZingade_-_2021_-_The_effect_of_traditional_aerobic_exercise_and_sprint_interval_training_on_insulin_resistance_in_men.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Banitalebi_-_2021_-_Sprint_interval_training_vs._combined_aerobic__resistance_training_in_overweight_women_with_type_2.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Cuddy_-_2019_-_Reduced_exertion_high-intensity_interval_training_is_more_effective_at_improving_cardiorespiratory_f.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Freese_-_2015_-_Acute_and_chronic_effects_of_sprint_interval_exercise_on_postprandial_lipemia_in_women_at-risk_for_t.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Gilbertson_-_2019_-_Combining_supervised_run_interval_training_or_moderate-intensity_continuous_training_with_the_diabet.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Honkala_-_2020_-_Exercise_training_improves_adipose_tissue_metabolism_and_vasculature_regardless_of_baseline_glucose.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Jimenez-Maldonado_-_2020_-_Impact_of_high-intensity_interval_training_and_sprint_interval_training_on_peripheral_markers_of_gly.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Motiani_-_2019_-_Effects_of_short-term_sprint_interval_and_moderate-intensity_continuous_training_on_liver_fat_conten.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Ortega_-_2014_-_Higher_insulin-sensitizing_response_after_sprint_interval_compared_to_continuous_exercise.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Petrick_-_2021_-_Endurance_and_sprint_training_improve_glycemia_and_V_O2peak_but_only_frequent_endurance_benefits_blo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Ruffino_-_2017_-_A_comparison_of_the_health_benefits_of_reduced-exertion_high-intensity_interval_training_REHIT_and.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Sjoros_-_2018_-_Increased_insulin-stimulated_glucose_uptake_in_both_leg_and_arm_muscles_after_sprint_interval_and_mo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Skleryk_-_2013_-_Two_weeks_of_reduced-volume_sprint_interval_or_traditional_exercise_training_does_not_improve_metabo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Sun_-_2019_-_Twelve_weeks_of_low_volume_sprint_interval_training_improves_cardio-metabolic_health_outcomes_in_ove.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| BadaamZingade_-_2021_-_The_effect_of_traditional_aerobic_exercise_and_sprint_interval_training_on_insulin_resistance_in_men.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Banitalebi_-_2021_-_Sprint_interval_training_vs._combined_aerobic__resistance_training_in_overweight_women_with_type_2.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
11.8%
2/17 passed |
2025-10-07 12:55:32 | ||
| Cuddy_-_2019_-_Reduced_exertion_high-intensity_interval_training_is_more_effective_at_improving_cardiorespiratory_f.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Freese_-_2015_-_Acute_and_chronic_effects_of_sprint_interval_exercise_on_postprandial_lipemia_in_women_at-risk_for_t.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
11.8%
2/17 passed |
2025-10-07 12:55:32 | ||
| Gilbertson_-_2019_-_Combining_supervised_run_interval_training_or_moderate-intensity_continuous_training_with_the_diabet.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-10-07 12:55:32 | ||
| Honkala_-_2020_-_Exercise_training_improves_adipose_tissue_metabolism_and_vasculature_regardless_of_baseline_glucose.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-10-07 12:55:32 | ||
| Jimenez-Maldonado_-_2020_-_Impact_of_high-intensity_interval_training_and_sprint_interval_training_on_peripheral_markers_of_gly.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Motiani_-_2019_-_Effects_of_short-term_sprint_interval_and_moderate-intensity_continuous_training_on_liver_fat_conten.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Ortega_-_2014_-_Higher_insulin-sensitizing_response_after_sprint_interval_compared_to_continuous_exercise.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-10-07 12:55:32 | ||
| Petrick_-_2021_-_Endurance_and_sprint_training_improve_glycemia_and_V_O2peak_but_only_frequent_endurance_benefits_blo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-10-07 12:55:32 | ||
| Skleryk_-_2013_-_Two_weeks_of_reduced-volume_sprint_interval_or_traditional_exercise_training_does_not_improve_metabo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-10-07 12:55:32 | ||
| Ruffino_-_2017_-_A_comparison_of_the_health_benefits_of_reduced-exertion_high-intensity_interval_training_REHIT_and.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
11.8%
2/17 passed |
2025-10-07 12:55:32 | ||
| Sjoros_-_2018_-_Increased_insulin-stimulated_glucose_uptake_in_both_leg_and_arm_muscles_after_sprint_interval_and_mo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
23.5%
4/17 passed |
2025-10-07 12:55:32 | ||
| Sun_-_2019_-_Twelve_weeks_of_low_volume_sprint_interval_training_improves_cardio-metabolic_health_outcomes_in_ove.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-10-07 12:55:32 | ||
| Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-10-07 12:55:32 | ||
| BadaamZingade_-_2021_-_The_effect_of_traditional_aerobic_exercise_and_sprint_interval_training_on_insulin_resistance_in_men.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
17.6%
3/17 passed |
2025-10-07 12:55:32 | ||
| Banitalebi_-_2021_-_Sprint_interval_training_vs._combined_aerobic__resistance_training_in_overweight_women_with_type_2.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
23.5%
4/17 passed |
2025-10-07 12:55:32 | ||
| Cuddy_-_2019_-_Reduced_exertion_high-intensity_interval_training_is_more_effective_at_improving_cardiorespiratory_f.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-10-07 12:55:32 | ||
| Freese_-_2015_-_Acute_and_chronic_effects_of_sprint_interval_exercise_on_postprandial_lipemia_in_women_at-risk_for_t.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
17.6%
3/17 passed |
2025-10-07 12:55:32 | ||
| Gilbertson_-_2019_-_Combining_supervised_run_interval_training_or_moderate-intensity_continuous_training_with_the_diabet.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
11.8%
2/17 passed |
2025-10-07 12:55:32 | ||
| Honkala_-_2020_-_Exercise_training_improves_adipose_tissue_metabolism_and_vasculature_regardless_of_baseline_glucose.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Jimenez-Maldonado_-_2020_-_Impact_of_high-intensity_interval_training_and_sprint_interval_training_on_peripheral_markers_of_gly.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Motiani_-_2019_-_Effects_of_short-term_sprint_interval_and_moderate-intensity_continuous_training_on_liver_fat_conten.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Ortega_-_2014_-_Higher_insulin-sensitizing_response_after_sprint_interval_compared_to_continuous_exercise.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-10-07 12:55:32 | ||
| Petrick_-_2021_-_Endurance_and_sprint_training_improve_glycemia_and_V_O2peak_but_only_frequent_endurance_benefits_blo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Ruffino_-_2017_-_A_comparison_of_the_health_benefits_of_reduced-exertion_high-intensity_interval_training_REHIT_and.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Sjoros_-_2018_-_Increased_insulin-stimulated_glucose_uptake_in_both_leg_and_arm_muscles_after_sprint_interval_and_mo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
17.6%
3/17 passed |
2025-10-07 12:55:32 | ||
| Skleryk_-_2013_-_Two_weeks_of_reduced-volume_sprint_interval_or_traditional_exercise_training_does_not_improve_metabo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-10-07 12:55:32 | ||
| Sun_-_2019_-_Twelve_weeks_of_low_volume_sprint_interval_training_improves_cardio-metabolic_health_outcomes_in_ove.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
11.8%
2/17 passed |
2025-10-07 12:55:32 | ||
| Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| BadaamZingade_-_2021_-_The_effect_of_traditional_aerobic_exercise_and_sprint_interval_training_on_insulin_resistance_in_men.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Banitalebi_-_2021_-_Sprint_interval_training_vs._combined_aerobic__resistance_training_in_overweight_women_with_type_2.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Cuddy_-_2019_-_Reduced_exertion_high-intensity_interval_training_is_more_effective_at_improving_cardiorespiratory_f.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Freese_-_2015_-_Acute_and_chronic_effects_of_sprint_interval_exercise_on_postprandial_lipemia_in_women_at-risk_for_t.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Gilbertson_-_2019_-_Combining_supervised_run_interval_training_or_moderate-intensity_continuous_training_with_the_diabet.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Honkala_-_2020_-_Exercise_training_improves_adipose_tissue_metabolism_and_vasculature_regardless_of_baseline_glucose.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Jimenez-Maldonado_-_2020_-_Impact_of_high-intensity_interval_training_and_sprint_interval_training_on_peripheral_markers_of_gly.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Motiani_-_2019_-_Effects_of_short-term_sprint_interval_and_moderate-intensity_continuous_training_on_liver_fat_conten.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Ortega_-_2014_-_Higher_insulin-sensitizing_response_after_sprint_interval_compared_to_continuous_exercise.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Petrick_-_2021_-_Endurance_and_sprint_training_improve_glycemia_and_V_O2peak_but_only_frequent_endurance_benefits_blo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Ruffino_-_2017_-_A_comparison_of_the_health_benefits_of_reduced-exertion_high-intensity_interval_training_REHIT_and.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Sjoros_-_2018_-_Increased_insulin-stimulated_glucose_uptake_in_both_leg_and_arm_muscles_after_sprint_interval_and_mo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Skleryk_-_2013_-_Two_weeks_of_reduced-volume_sprint_interval_or_traditional_exercise_training_does_not_improve_metabo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Sun_-_2019_-_Twelve_weeks_of_low_volume_sprint_interval_training_improves_cardio-metabolic_health_outcomes_in_ove.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| elife-04490-v2.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-10-07 12:55:32 | ||
| Berinstein_1998.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
100.0%
17/17 passed |
2025-10-07 12:55:32 | ||
| Ipek_2021.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
88.2%
15/17 passed |
2025-10-07 12:55:32 | ||
| Saedi_2016.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
94.1%
16/17 passed |
2025-10-07 12:55:32 | ||
| Vural_2023.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
100.0%
17/17 passed |
2025-10-07 12:55:32 | ||
| Vural_2025.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
100.0%
17/17 passed |
2025-10-07 12:55:32 | ||
| JSURGRES-D-25-01704_1.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-10-07 12:55:32 | ||
| NEJMoa1503093.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| World_j_surg_-_2004_-_Wang_-_Molecular_Detection_of_APC_Kras_and_p53_Mutations_in_the_Serum_of_Colorectal_Cancer.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-10-07 12:55:32 | ||
| carroll_2024_oi_231495_1704490532.6214.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| The_impact_of_using_pictorial_aids_in_caregivers__3.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Yin_et_al._-_2021_-_Preventing_Home_Medication_Administration_Errors.pdf | Unknown | - | Completed | - | 2025-10-07 12:55:32 | ||
| j_acap_2010_12_007_--_7ccfa682a71ef7b8dd9a46bb8f21954c_--_Annas_Archive_1.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| EBSCO-FullText-08_26_2025_2.pdf | Unknown | - | Completed | - | 2025-10-07 12:55:32 | ||
| Journal_of_Advanced_Nursing_-_2014_-_He_-_A_randomized_controlled_trial_of_the_effectiveness_of_an_educational_intervention.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| The_impact_of_using_pictorial_aids_in_caregivers__3.pdf | Case-Control Study | Newcastle-Ottawa Scale (NOS) for Case-Control Studies | Completed |
0.0%
0/8 passed |
2025-10-07 12:55:32 | ||
| Yin_et_al._-_2021_-_Preventing_Home_Medication_Administration_Errors.pdf | Qualitative Study | - | Completed | - | 2025-10-07 12:55:32 | ||
| s13287-025-04377-4.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| pubmed.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-10-07 12:55:32 | ||
| bhan.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| scrt446.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| AICARE.pdf | Unknown | - | Completed | - | 2025-10-07 12:55:32 | ||
| artikel_1.pdf | Cross-sectional Study | AXIS Tool for Cross-sectional Studies | Completed |
0.0%
0/10 passed |
2025-10-07 12:55:32 | ||
| artikel_2.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
0.0%
0/13 passed |
2025-10-07 12:55:32 | ||
| artikel_3.pdf | Unknown | - | Completed | - | 2025-10-07 12:55:32 | ||
| artikel_1.pdf | Cross-sectional Study | AXIS Tool for Cross-sectional Studies | Completed |
0.0%
0/10 passed |
2025-10-07 12:55:32 | ||
| Kang-2024.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-10-07 12:55:32 | ||
| Kang-2023-Management-of-asymptomatic-to-mild-.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-10-07 12:55:32 | ||
| Kang-2021.pdf | Unknown | - | Completed | - | 2025-10-07 12:55:32 | ||
| 2021.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| 2019.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| 2021.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Liu2018.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 | ||
| Ye2024.pdf | Unknown | - | Completed | - | 2025-10-07 12:55:32 | ||
| Ye2024.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-10-07 12:55:32 |